Dengue Fever Complicated with Hemophagocytic Lymphohistiocytosis: A Case Report of Resolution with Steroid-Sparing Supportive Care

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

Simmons, C.P.; Farrar, J.J.; Nguyen, v.V.; Wills, B. Dengue. N. Engl. J. Med. 2012, 366, 1423–1432. [CrossRef] [PubMed]

Dengue: Guidelines for Diagnosis, Treatment. Available online: https://pubmed.ncbi.nlm.nih.gov/23762963/ (accessed on 1

September 2023).

La Russa, V.F.; Innis, B.L. Mechanisms of dengue virus-induced bone marrow suppression. Bailliere’s Clin. Haematol. 1995, 8,

249–270. [CrossRef] [PubMed]

Saito, M.; Oishi, K.; Inoue, S.; Dimaano, E.M.; Alera, M.T.; Robles, A.M.; Estrella, B.D., Jr.; Kumatori, A.; Moji, K.; Alonzo,

M.T.; et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in

secondary dengue virus infections. Clin. Exp. Immunol. 2004, 138, 299–303. [CrossRef] [PubMed]

Roy, M.; Bandyopadhyay, D.; Saha, K.; Sarkar, S.; Ranjit, P.; Thiyagarajan, G.; Mondal, R.S.; Naskar, S.; Patra, S. Hemophagocytosis

in dengue. Assam J. Intern. Med. 2013, 3, 27–29.

Wan Jamaludin, W.F.; Periyasamy, P.; Wan Mat, W.R.; Abdul Wahid, S.F. Dengue infection associated hemophagocytic syndrome:

Therapeutic interventions and outcome. J. Clin. Virol. 2015, 69, 91–95. [CrossRef]

Chung, S.M.; Song, J.Y.; Kim, W.; Choi, M.J.; Jeon, J.H.; Kang, S.; Jung, E.; Noh, J.Y.; Cheong, H.J.; Kim, W.J. Dengue-associated

hemophagocytic lymphohistiocytosis in an adult: A case report and literature review. Medicine 2017, 96, e6159. [CrossRef]

[PubMed]

Henter, J.I.; Horne, A.; Aricó, M.; Egeler, R.M.; Filipovich, A.H.; Imashuku, S.; Ladisch, S.; McClain, K.; Webb, D.; Winiarski, J.;

et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007, 48,

124–131. [CrossRef]

Fardet, L.; Galicier, L.; Lambotte, O.; Marzac, C.; Aumont, C.; Chahwan, D.; Coppo, P.; Hejblum, G. Development and validation

of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66, 2613–2620. [CrossRef]

Imashuku, S.; Ueda, I.; Teramura, T.; Mori, K.; Morimoto, A.; Sako, M.; Ishii, E. Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: Analysis of 96 patients. Eur. J. Pediatr. 2005, 164, 315–319. [CrossRef]

Russell, J.H.; Ley, T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 2002, 20, 323–370. [CrossRef]

Risma, K.A.; Frayer, R.W.; Filipovich, A.H.; Sumegi, J. Aberrant maturation of mutant perforin underlies the clinical diversity of

hemophagocytic lymphohistiocytosis. J. Clin. Investig. 2006, 116, 182–192. [CrossRef] [PubMed]

Jordan, M.B.; Hildeman, D.; Kappler, J.; Marrack, P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T

cells and interferon gamma are essential for the disorder. Blood 2004, 104, 735–743. [CrossRef]

Janka, G.E.; Schneider, E.M. Modern management of children with haemophagocytic lymphohistiocytosis. Br. J. Haematol. 2004,

124, 4–14. [CrossRef] [PubMed]

Arnaout, R.A. Perforin deficiency: Fighting unarmed? Immunol. Today 2000, 21, 592. [CrossRef] [PubMed]

Trop. Med. Infect. Dis. 2023, 8, 497

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

9 of 9

Moretta, L.; Moretta, A.; Hengartner, H.; Zinkernagel, R.M. On the pathogenesis of perforin defects and related immunodeficiencies. Immunol. Today 2000, 21, 593–594. [CrossRef] [PubMed]

Katano, H.; Cohen, J.I. Perforin and lymphohistiocytic proliferative disorders. Br. J. Haematol. 2005, 128, 739–750. [CrossRef]

[PubMed]

Homchampa, P.; Sarasombath, S.; Suvatte, V.; Vongskul, M. Natural killer cells in dengue hemorrhagic fever/dengue shock

syndrome. Asian Pac. J. Allergy Immunol. 1988, 6, 95–102.

Matangkasombut, P.; Chan-In, W.; Opasawaschai, A.; Pongchaikul, P.; Tangthawornchaikul, N.; Vasanawathana, S.; Limpitikul,

W.; Malasit, P.; Duangchinda, T.; Screaton, G.; et al. Invariant NKT cell response to dengue virus infection in human. PLOS Negl.

Trop. Dis. 2014, 8, e2955. [CrossRef]

Sun, W.; Wang, Y.; East, J.E.; Kimball, A.S.; Tkaczuk, K.; Kesmodel, S.; Strome, S.E.; Webb, T.J. Invariant natural killer T cells

generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine 2015, 72, 48–57. [CrossRef]

Ramanathan, M.; Duraisamy, G. Haemophagocytosis in dengue haemorrhagic fever: A case report. Ann. Acad. Med. Singap. 1991,

20, 803–804.

Wong, K.F.; Chan, J.K.; Chan, J.C.; Lim, W.W.; Wong, W.K. Dengue virus infection-associated hemophagocytic syndrome. Am. J.

Hematol. 1991, 38, 339–340. [CrossRef] [PubMed]

Lu, P.L.; Hsiao, H.H.; Tsai, J.J.; Chen, T.C.; Feng, M.C.; Chen, T.P.; Lin, S.F. Dengue virus-associated hemophagocytic syndrome

and dyserythropoiesis: A case report. Kaohsiung J. Med. Sci. 2005, 21, 34–39. [CrossRef]

Srichaikul, T.; Punyagupta, S.; Kanchanapoom, T.; Chanokovat, C.; Likittanasombat, K.; Leelasiri, A. Hemophagocytic synrome in

dengue hemorrhagic fever with severe multiorgan complications. J. Med. Assoc. Thai. 2008, 91, 104–109. [PubMed]

Nakamura, I.; Nakamura-Uchiyama, F.; Komiya, N.; Ohnishi, K. A case of dengue fever with viral-associated hemophagocytic

syndrome. Kansenshogaku Zasshi 2009, 83, 60–63. (In Japanese) [CrossRef]

Ray, S.; Kundu, S.; Saha, M.; Chakrabarti, P. Hemophagocytic syndrome in classic dengue fever. J. Glob. Infect. Dis. 2011, 3,

399–401. [CrossRef]

Sorakhunpipitkul, L.; Punyagupta, S.; Srichaikul, T.; Tribuddharat, S. Thai adult dengue hemorrhagic fever during 2008–2010:

Seven cases presented with severe multiorgan failure and successfully treated with high dose of corticosteroids and intravenous

immunoglobulin G. J. Infect. Dis. Antimicrob. Agents 2011, 28, 99–103.

Tan, L.H.; Lum, L.C.; Omar, S.F.; Kan, F.K. Hemophagocytosis in dengue: Comprehensive report of six cases. J. Clin. Virol. 2012,

55, 79–82. [CrossRef]

Ribeiro, E.; Kassab, S.; Pistone, T.; Receveur, M.C.; Fialon, P.; Malvy, D. Primary dengue fever associated with hemophagocytic

syndrome: A report of three imported cases, Bordeaux, France. Intern. Med. 2014, 53, 899–902. [CrossRef]

De Koninck, A.S.; Dierick, J.; Steyaert, S.; Taelman, P. Hemophagocytic lymphohistiocytosis and dengue infection: Rare case

report. Acta Clin. Belg. 2014, 69, 210–213. [CrossRef]

Sharp, T.M.; Gaul, L.; Muehlenbachs, A.; Hunsperger, E.; Bhatnagar, J.; Lueptow, R.; Santiago, G.A.; Muñoz-Jordan, J.L.; Blau,

D.M.; Ettestad, P.; et al. Fatal hemophagocytic lymphohistiocytosis associated with locally acquired dengue virus infection—New

Mexico and Texas, 2012. MMWR Morb. Mortal. Wkly. Rep. 2014, 63, 49–54.

Arshad, U.; Ahmad, S.Q.; Khan, F. Hemophagocytic lymphohistiocytosis in a patient with dengue infection. Hematol. Oncol. Stem

Cell Ther. 2015, 8, 189–190. [CrossRef] [PubMed]

Yoshifuji, K.; Oshina, T.; Sonokawa, S.; Noguchi, Y.; Suzuki, S.; Tanaka, K.; Kumagai, T. Domestic dengue infection with

hemophagocytic lymphohistiocytosis successfully treated by early steroid therapy. Rinsho Ketsueki 2016, 57, 864–868. (In Japanese)

[CrossRef]

Jasmine, Y.S.; Lee, S.L.; Kan, F.K. Infection associated haemophagocytic syndrome in severe dengue infection—A case series in a

district hospital. Med. J. Malaysia 2017, 72, 62–64. [PubMed]

Anam, A.M.; Rabbani, R.; Shumy, F. Expanded dengue syndrome: Three concomitant uncommon presentations in the same

patient. Trop. Dr. 2017, 47, 167–170. [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual

author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to

people or property resulting from any ideas, methods, instructions or products referred to in the content.

...